260 related articles for article (PubMed ID: 20310042)
1. Successful treatment of advanced bisphosphonate-related osteonecrosis of the mandible with adjunctive teriparatide therapy.
Lee JJ; Cheng SJ; Jeng JH; Chiang CP; Lau HP; Kok SH
Head Neck; 2011 Sep; 33(9):1366-71. PubMed ID: 20310042
[TBL] [Abstract][Full Text] [Related]
2. Teriparatide therapy for bisphosphonate-related osteonecrosis of the jaw: a case report and narrative review.
Thumbigere-Math V; Gopalakrishnan R; Michalowicz BS
Northwest Dent; 2013; 92(1):12-8. PubMed ID: 23516715
[TBL] [Abstract][Full Text] [Related]
3. Adjunct teriparatide therapy with monitoring of bone turnover markers and bone scintigraphy for bisphosphonate-related osteonecrosis of the jaw.
Ohbayashi Y; Miyake M; Sawai F; Minami Y; Iwasaki A; Matsui Y
Oral Surg Oral Med Oral Pathol Oral Radiol; 2013 Apr; 115(4):e31-7. PubMed ID: 23246226
[TBL] [Abstract][Full Text] [Related]
4. Administration of teriparatide improves the symptoms of advanced bisphosphonate-related osteonecrosis of the jaw: preliminary findings.
Kakehashi H; Ando T; Minamizato T; Nakatani Y; Kawasaki T; Ikeda H; Kuroshima S; Kawakami A; Asahina I
Int J Oral Maxillofac Surg; 2015 Dec; 44(12):1558-64. PubMed ID: 26304604
[TBL] [Abstract][Full Text] [Related]
5. The role of surgical resection in the management of bisphosphonate-related osteonecrosis of the jaws.
Carlson ER; Basile JD
J Oral Maxillofac Surg; 2009 May; 67(5 Suppl):85-95. PubMed ID: 19371819
[TBL] [Abstract][Full Text] [Related]
6. Short-term teriparatide therapy as an adjunctive modality for bisphosphonate-related osteonecrosis of the jaws.
Kwon YD; Lee DW; Choi BJ; Lee JW; Kim DY
Osteoporos Int; 2012 Nov; 23(11):2721-5. PubMed ID: 22218418
[TBL] [Abstract][Full Text] [Related]
7. Treatment of Osteonecrosis of the Jaw.
Yamachika E; Matsubara M; Ikeda A; Matsumura T; Moritani N; Iida S
J Craniofac Surg; 2015 Oct; 26(7):e575-7. PubMed ID: 26468825
[TBL] [Abstract][Full Text] [Related]
8. The effects of adjunctive parathyroid hormone injection on bisphosphonate-related osteonecrosis of the jaws: an animal study.
Dayisoylu EH; Şenel FÇ; Üngör C; Tosun E; Çankaya M; Ersöz S; Taskesen F
Int J Oral Maxillofac Surg; 2013 Nov; 42(11):1475-80. PubMed ID: 23746422
[TBL] [Abstract][Full Text] [Related]
9. Teriparatide therapy for bisphosphonate-related osteonecrosis of the jaw associated with dental implants.
Doh RM; Park HJ; Rhee Y; Kim HS; Huh J; Park W
Implant Dent; 2015 Apr; 24(2):222-6. PubMed ID: 25734949
[TBL] [Abstract][Full Text] [Related]
10. Management of bisphosphonate-related osteonecrosis of the jaw: a literature review.
Spanou A; Lyritis GP; Chronopoulos E; Tournis S
Oral Dis; 2015 Nov; 21(8):927-36. PubMed ID: 25732104
[TBL] [Abstract][Full Text] [Related]
11. Alternative treatments for oral bisphosphonate-related osteonecrosis of the jaws: a pilot study comparing fibrin rich in growth factors and teriparatide.
Pelaz A; Junquera L; Gallego L; García-Consuegra L; Junquera S; Gómez C
Med Oral Patol Oral Cir Bucal; 2014 Jul; 19(4):e320-6. PubMed ID: 24608203
[TBL] [Abstract][Full Text] [Related]
12. A case of early detection of bisphosphonate-related osteonecrosis of the jaw.
Mori M; Koide T; Matsui Y; Matsuda T
Indian J Pharmacol; 2015; 47(3):334-5. PubMed ID: 26069377
[TBL] [Abstract][Full Text] [Related]
13. Bisphosphonate-related osteonecrosis of the jaw: clinical features, risk factors, management, and treatment outcomes of 26 patients.
Thumbigere-Math V; Sabino MC; Gopalakrishnan R; Huckabay S; Dudek AZ; Basu S; Hughes PJ; Michalowicz BS; Leach JW; Swenson KK; Swift JQ; Adkinson C; Basi DL
J Oral Maxillofac Surg; 2009 Sep; 67(9):1904-13. PubMed ID: 19686928
[TBL] [Abstract][Full Text] [Related]
14. Weekly teriparatide injections successfully treated advanced bisphosphonate-related osteonecrosis of the jaws.
Yoshiga D; Yamashita Y; Nakamichi I; Tanaka T; Yamauchi K; Yamamoto N; Nogami S; Kaneuji T; Mitsugi S; Sakurai T; Kiyomiya H; Tominaga K; Morimoto Y; Takahashi T
Osteoporos Int; 2013 Aug; 24(8):2365-9. PubMed ID: 23371327
[TBL] [Abstract][Full Text] [Related]
15. [Potential use of parathyroid hormone (PTH) in the treatments for oral diseases].
Tanaka S; Hata K; Yoneda T
Clin Calcium; 2012 Jan; 22(1):75-82. PubMed ID: 22201102
[TBL] [Abstract][Full Text] [Related]
16. Distinctive role of 6-month teriparatide treatment on intractable bisphosphonate-related osteonecrosis of the jaw.
Kim KM; Park W; Oh SY; Kim HJ; Nam W; Lim SK; Rhee Y; Cha IH
Osteoporos Int; 2014 May; 25(5):1625-32. PubMed ID: 24554340
[TBL] [Abstract][Full Text] [Related]
17. Bisphosphonate-Related Osteonecrosis of the Jaw (BRONJ) therapy. A critical review.
Vescovi P; Nammour S
Minerva Stomatol; 2010 Apr; 59(4):181-203, 204-13. PubMed ID: 20360666
[TBL] [Abstract][Full Text] [Related]
18. Outcome of surgical management of bisphosphonate-related osteonecrosis of the jaws: review of 33 surgical cases.
Stanton DC; Balasanian E
J Oral Maxillofac Surg; 2009 May; 67(5):943-50. PubMed ID: 19375001
[TBL] [Abstract][Full Text] [Related]
19. Could teriparatide be the treatment for osteonecrosis of the jaws?
Kyrgidis A; Antoniades K
Head Neck; 2011 Sep; 33(9):1382-3; author reply 1383. PubMed ID: 20687167
[No Abstract] [Full Text] [Related]
20. A model for the pathogenesis of bisphosphonate-associated osteonecrosis of the jaw and teriparatide's potential role in its resolution.
Subramanian G; Cohen HV; Quek SY
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2011 Dec; 112(6):744-53. PubMed ID: 21821444
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]